Back to top
more

Cabot (CBT)

(Real Time Quote from BATS)

$73.41 USD

73.41
191,840

+1.41 (1.96%)

Updated Aug 4, 2025 01:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (233 out of 246)

Industry: Chemical - Diversified

Zacks News

Zacks Equity Research

Cabot's (CBT) Earnings and Sales Surpass Estimates in Q3

Cabot (CBT) gains on higher margins and stronger volumes across the board in the fiscal third quarter.

Zacks Equity Research

Veritiv (VRTV) Surpasses Q2 Earnings Estimates, Hikes '22 View

Veritiv's (VRTV) Q2 results gain from double-digit sales growth and year-over-year adjusted EBITDA margin improvements across each segment.

Zacks Equity Research

Endeavour Silver (EXK) Q2 Earnings & Revenues Miss Estimates

Endeavour Silver (EXK) reports soft revenues and a loss for Q2, mainly due to its decision to hold a certain amount of silver in its inventory amid the prevailing lower silver prices.

Zacks Equity Research

Comstock Mining (LODE) Q2 Earnings & Revenues Miss Estimates

Comstock Mining (LODE) reported a loss per share of 20 cents for the second quarter of 2022 due to higher research and development expenditures, and changes in fair values of derivatives.

Zacks Equity Research

Great Panther (GPL) Q2 Earnings & Revenues Miss Estimates

Great Panther (GPL) reports a second-quarter 2022 loss on lower metal sales volumes and inflationary pressures, somewhat offset by higher metal prices.

Zacks Equity Research

Hecla Mining (HL) Q2 Earnings Beat Estimates, Revenues Lag

Hecla Mining (HL) reports a year-on-year decline in both earnings and revenues in Q2 on lower metal prices, while production improved 3% year on year.

Zacks Equity Research

Barrick's (GOLD) Earnings Beat Estimates in Q2, Revenues Lag

Barrick (GOLD) benefits from strong performance across the portfolio in Q2 amid challenges from higher costs and lower copper prices.

Zacks Equity Research

Scotts Miracle-Gro (SMG) Q3 Earnings Beat Estimates, Sales Miss

Scotts Miracle-Gro (SMG) sees lower-than-expected sales in the U.S. Consumer segment and sustained pressure on sales in the Hawthorne unit in Q3.

Zacks Equity Research

Cabot (CBT) Q3 Earnings and Revenues Top Estimates

Cabot (CBT) delivered earnings and revenue surprises of 13.07% and 10.15%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

MP Materials (MP) Q2 Earnings & Sales Top Estimates, Up Y/Y

MP Materials' (MP) Q2 results reflect gains from strong demand for rare earth materials and upbeat realized sales prices of REO in concentrate.

Zacks Equity Research

Are Basic Materials Stocks Lagging CalMaine Foods (CALM) This Year?

Here is how Cal-Maine Foods (CALM) and Cabot (CBT) have performed compared to their sector so far this year.

Zacks Equity Research

Ingevity's (NGVT) Earnings and Sales Top Estimates in Q2

Ingevity (NGVT) benefits from actions to increase prices to offset inflationary cost pressures in Q2.

Zacks Equity Research

Nutrien's (NTR) Earnings and Revenues Lag Estimates in Q2

Nutrien (NTR) gains on higher selling prices and strong Retail performance in Q2 amid headwinds from weak volumes in North America and higher natural gas costs.

Zacks Equity Research

Royal Gold (RGLD) Q2 Earnings & Sales Miss Estimates, Down Y/Y

Royal Gold's (RGLD) Q2 top line declines year over year on lower gold sales at Andacollo and Pueblo Viejo and lower gold production at Cortez and Pe??asquito mines.

Zacks Equity Research

Zacks.com featured highlights include Apogee Enterprises, Cabot Corporation, STMicroelectronics, United Rentals and ProPetro Holding

Apogee Enterprises, Cabot Corporation, STMicroelectronics, United Rentals and ProPetro Holding are part of Zacks Screen of the Week article.

Zacks Equity Research

GrowGeneration (GRWG) Q2 Earnings Miss, Lowers '22 View

GrowGeneration (GRWG) reports a drop in Q2 revenues due to the ongoing weakness in the cannabis industry. It lowers revenue guidance to $250 million and $275 million for 2022.

Zacks Equity Research

Westlake's (WLK) Earnings & Revenues Surpass Estimates in Q2

Westlake (WLK) gains on continued strength in residential construction and remodeling activities in Q2.

Zacks Equity Research

Huntsman's (HUN) Earnings and Revenues Top Estimates in Q2

Huntsman (HUN) benefits from improved pricing, cost-control actions and its volume strategy in the second quarter.

Zacks Equity Research

WestRock (WRK) Earnings Surpass Estimates in Q3, Up Y/Y

WestRock (WRK) reports a year-over-year increase in Q3 earnings and record revenues on improved performances across all of its segments and higher selling price/mix.

Zacks Equity Research

B2Gold (BTG) Earnings Miss Estimates in Q2, Decline Y/Y

B2Gold's (BTG) Q2 top line gains from the increased average realized gold prices and higher gold ounces sold.

Zacks Equity Research

Air Products (APD) Earnings and Sales Beat Estimates in Q3

Air Products (APD) gains on increased pricing, higher equity affiliates' income and higher volumes in Q3.

Rimmi Singhi headshot

5 Value Stocks With High Earnings Yield to Boost Returns

Power your portfolio with five high earnings yield stocks namely, APOG, CBT, STM, URI and PUMP.

Zacks Equity Research

Air Products and Chemicals (APD) Q3 Earnings and Revenues Top Estimates

Air Products and Chemicals (APD) delivered earnings and revenue surprises of 0.38% and 4.22%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Albemarle (ALB) Beats on Q2 Earnings and Sales, Raises FY22 View

Higher pricing on the back of strong demand from diverse end markets drives Albemarle's (ALB) top line in Q2.

Zacks Equity Research

Cabot (CBT) to Report Q3 Earnings: What's in the Cards?

Cabot (CBT) is likely to have benefited from strong demand and higher prices across its segments in the fiscal third quarter.